Piperidine

Piperidine

SCHEMBL5874676

C1CCNCC1.C1CCNCC1.O=S(=O)(O)O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Piperidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.60
LMNA P02545 1/20 0.43
CYP3A4 P08684 1/20 0.43
GABRA1 P14867 1/20 0.43
TSHR P16473 1/20 0.43
GABRG2 P18507 1/20 0.43
NFKB1 P19838 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA5 P31644 1/20 0.43
GABRA3 P34903 1/20 0.43
GABRA2 P47869 1/20 0.43
GABRA6 Q16445 1/20 0.43
CXCR4 P61073 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KDM4E B2RXH2 1/20 0.40
CA5A P35218 1/20 0.40
CA5B Q9Y2D0 1/20 0.40
CA2 P00918 1/20 0.35
CHKA P35790 1/20 0.35
APLNR P35414 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperidine SCHEMBL4439035 1.00 ALDH1A1 (0.60) ALDH1A1LMNACYP3A4GABRA1TSHR
Sulfuric Acid SCHEMBL28813640 1.00 ALDH1A1 (0.60) ALDH1A1LMNACYP3A4GABRA1TSHR
Azepane SCHEMBL29144238 1.00 ALDH1A1 (0.60) ALDH1A1LMNACYP3A4GABRA1TSHR
Piperidine SCHEMBL18091131 0.97 ALDH1A1 (0.56) ALDH1A1LMNACYP3A4GABRA1TSHR
Piperidine SCHEMBL27494539 0.97 ALDH1A1 (0.56) ALDH1A1LMNACYP3A4GABRA1TSHR
Piperidine SCHEMBL29877069 0.97 ALDH1A1 (0.56) ALDH1A1LMNACYP3A4GABRA1TSHR
Pyrrolidine SCHEMBL28642083 0.97 ALDH1A1 (0.53) ALDH1A1LMNACYP3A4GABRA1TSHR
Pyrrolidine SCHEMBL3835047 0.97 ALDH1A1 (0.53) ALDH1A1LMNACYP3A4GABRA1TSHR
Pyrrolidine SCHEMBL27815363 0.93 ALDH1A1 (0.50) ALDH1A1LMNACYP3A4GABRA1TSHR
Sulfuric Acid SCHEMBL7741636 0.89 CA5A (0.50) ALDH1A1LMNACYP3A4GABRA1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105541664-B A kind of method for synthesizing cyanoacrylate 潍坊同业化学有限公司 2018-01-30 CN claimed
CN-105541664-A Method for synthesizing cyanoacrylate WEIFANG TONGYE CHEMICAL CO LTD 2016-05-04 CN claimed
CN-105541664-B A kind of method for synthesizing cyanoacrylate 潍坊同业化学有限公司 2018-01-30 CN disclosed
CN-105017137-B One kind prepares vitamin B by malic acid6Method 新发药业有限公司 2018-01-26 CN disclosed
CN-105541664-A Method for synthesizing cyanoacrylate WEIFANG TONGYE CHEMICAL CO LTD 2016-05-04 CN disclosed
CN-105017137-A Method of using malic acid to prepare vitamin B6 XINFA PHARMACEUTICAL CO LTD 2015-11-04 CN disclosed
US-7128976-B2 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2006-10-31 US disclosed
WO-2006018249-A1 METHOD FOR THE PRODUCTION OF QUARTERNARY AMMONIA COMPOUNDS AT ATMOSPHERIC PRESSURE BASF AKTIENGESELLSCHAFT (DE) 2006-02-23 WO disclosed
US-20030091838-A1 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2003-05-15 US disclosed